Streptococcus pneumoniae

Tiny germs live in our noses and throats.

Most of the time, they do not hurt us. But sometimes, they can make people sick. These germs can cause a bad cough. They can also cause ear or sinus pain.

This often happens to young children or old people. The germs spread when people get close to each other. Doctors use special shots to keep us safe. These shots help our bodies fight the germs.

Tiny germs called *Streptococcus pneumoniae* live in our noses and throats.

Most people carry them without feeling sick. However, these germs can cause many illnesses. They often make young children or older people sick.

This germ can cause pneumonia. This is a lung infection that makes it hard to breathe. It can also cause meningitis. This is an infection that reaches the brain and spinal cord. Other problems include ear infections and sinus pain.

These germs have a special outer layer. This layer is a polysaccharide capsule. It acts like a shield. This shield helps the germ hide from the body's defenses. The germ can also change its look. It can grow a thick capsule to survive in the blood.

Scientists study these germs to learn about life. In 1944, researchers used them to prove that DNA is important. DNA is the code that tells living things how to grow. Today, we use vaccines to stay safe. These shots teach the body how to fight the germs.

Tiny germs called *Streptococcus pneumoniae* are found in many people.

Most people carry them in their noses or throats without feeling sick. These germs are spherical, which means they are shaped like little balls. They often live in pairs, a form called diplococci. While they are usually harmless, they can cause serious illness in some people. This often happens to young children or the elderly. These groups may have weaker immune systems that cannot fight the germs easily. When the germs spread, they can cause many different problems.

These germs have a special way of working to stay alive. They have an outer layer called a polysaccharide capsule. This capsule acts like a shield to protect the germ. It is a thick, sticky substance that helps the bacteria hide. This shield stops the body's white blood cells from reaching the cell wall. The bacteria can even change their look to survive better. They can grow a thin capsule to stick to the throat. Or, they can grow a thick capsule to travel through the blood.

Scientists have studied these germs for a long time to understand life. In 1881, George Sternberg and Louis Pasteur found the germ separately. Later, in 1928, Frederick Griffith showed how germs can change. He used a mouse to show how harmless germs could become deadly. In 1944, Avery, MacLeod, and McCarty finished this discovery. They proved that DNA was the factor that caused the change. This work helped start the modern era of studying genetics. It showed that DNA is the important code for all living things.

There are many different types of these germs. Scientists call these different types serotypes. There are more than 100 different serotypes known today. These types can vary in how strong they are. They also differ in how well they resist medicine. The germ's DNA is a closed circle. It contains between 2.0 and 2.1 million base pairs. It also has a core set of 1,553 genes. These genes help the germ survive and cause disease.

Knowing about these germs helps us stay healthy. Many illnesses come from *Streptococcus pneumoniae*. Pneumonia is a common lung infection that causes coughing and fever. It can also cause meningitis, which affects the brain and spinal cord. Other issues include ear infections or sinus pain. To help, doctors use vaccines to protect people. There are two main types of vaccines used today. One is called the polysaccharide vaccine, or PPV23. The other is the conjugate vaccine, or PCV13. These shots teach the body how to fight the germs.

*Streptococcus pneumoniae*, often called pneumococcus, is a significant human pathogen. It is a Gram-positive, spherical bacterium that typically lives in pairs, a form known as diplococci.

While many healthy people carry these bacteria in their respiratory tract, sinuses, or nasal cavity without symptoms, they can become dangerous to certain groups. People with weaker immune systems, such as the elderly and young children, are at higher risk. In these individuals, the bacteria can spread and cause serious invasive diseases.

The bacterium uses several mechanisms to survive within a human host. A primary tool is its polysaccharide capsule (CPS), which is a thick, outer layer of repeating sugar units. This capsule acts as a virulence factor by inhibiting phagocytosis. This means it prevents granulocytes, a type of white blood cell, from reaching and destroying the bacterial cell wall. The bacteria also use a process called phase variation to change their physical appearance. They can switch to a transparent phenotype with a thin capsule to better adhere to the nasopharynx. Alternatively, they can switch to an opaque phenotype with a thicker capsule to survive more effectively in the bloodstream.

There are many different versions of this bacterium, categorized into more than 100 known serotypes. These serotypes are determined by the chemical composition and quantity of the polysaccharide capsule they produce. These differences are important because they influence how much damage the bacteria cause, how common they are, and how well they resist drugs.

Scientists can distinguish *S. pneumoniae* from similar bacteria using specific laboratory tests. One method is the optochin test, as this bacterium is sensitive to the chemical optochin. Another method is the bile solubility test, which checks if the bacteria break apart when exposed to bile.

The history of studying this organism is linked to the very foundation of modern genetics. In 1881, George Sternberg and Louis Pasteur independently isolated the organism. It was later known as *Diplococcus pneumoniae* due to its appearance in Gram-stained sputum, before being renamed in 1974. In 1928, Frederick Griffith conducted a famous experiment using mice. He showed that harmless bacteria could be transformed into a lethal form by mixing them with heat-killed virulent bacteria. In 1944, researchers Oswald Avery, Colin MacLeod, and Maclyn McCarty proved that DNA was the substance responsible for this transformation. This discovery helped launch the molecular era of genetics.

*S. pneumoniae* can cause a wide range of infections with varying levels of severity. Pneumonia is the most common disease, causing fever, chills, and labored breathing. In the elderly, patients might show tachypnea, which is rapid and shallow breathing, before other symptoms appear. The bacteria can also cause meningitis, an infection of the brain and spinal cord. This can lead to severe disabilities, such as hearing loss or brain damage. Other infections include sepsis, which is an overwhelming body response to infection, and osteomyelitis, a rare bone infection. Less severe examples include otitis media (ear infections), sinusitis, and conjunctivitis.

The genetic makeup of the bacterium is quite complex. Its genome consists of a closed, circular DNA structure containing between 2.0 and 2.1 million base pairs. This genome includes a core set of 1,553 genes, along with 154 genes that contribute to its ability to cause disease. The bacteria also use a process called transformation to survive. This involves taking up DNA from their surroundings to repair damage. This process requires a special state called competence, which can be triggered by certain antibiotics. This ability to repair DNA helps the bacteria survive the oxidative stress produced by the human immune system.

To protect populations, scientists have developed two main types of vaccines. The pneumococcal polysaccharide vaccine (PPV23) uses the capsule to help the body create specific antibodies. However, this vaccine provides temporary immunity and requires a booster after five years. To better protect young children, the pneumococcal conjugate vaccine (PCV13) was developed. This vaccine creates a more enduring immune response by promoting interaction between B cells and T cells.

These medical advancements are essential for reducing the impact of this widespread pathogen.